Adverse reactions associated with meningococcal group B vaccine (4CMenB) in adults in special situations
MENINGOCOCCAL GROUP B VACCINE (BEXSERO) Information for Health Professionals
Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention | Immunotherapy
Bexsero - NPS MedicineWise
Post-licensure observational safety study after meningococcal B vaccine 4CMenB (Bexsero) vaccination within the routine UK immunisation program - ScienceDirect
Bexsero - NPS MedicineWise
Bexsero Full Prescribing Information, Dosage & Side Effects | MIMS Hong Kong
Bexsero - NPS MedicineWise
PDF) Post-licensure observational safety study after meningococcal B Vaccine (4CMenB) vaccination in routine UK care DOI10.1002/pds.5114
Frontiers | The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
Package leaflet: information for the user Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine
Vacuna del meningococo B, y tetravalente meningococos ACWY. | Consultas Frecuentes | Tu Pediatra Online
Full article: Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review
Physicians for Informed Consent - Did you know that Bexsero Meningococcal B vaccine may predispose children towards Kawasaki disease? Listed under Possible Side Effects: “Rare (these may affect up to 1 in
Meningococcal B Vaccine - Bexsero - Child Health
Frontiers | The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
The risk of Kawasaki disease after pneumococcal conjugate & meningococcal B vaccine in England: A self-controlled case-series analysis - ScienceDirect
Lo que debes saber acerca del riesgo de padecer la enfermedad de Kawasaki tras la vacunación con Bexsero
In vitro alternative for reactogenicity assessment of outer membrane vesicle based vaccines | Scientific Reports
Post-licensure observational safety study after meningococcal B vaccine 4CMenB (Bexsero) vaccination within the routine UK immun
PDF) Kawasaki disease incidence in children and adolescents: An observational study in primary care
Urticarial vasculitis after meningococcal serogroup B vaccine in a 6‐year‐old girl - Velasco‐Tamariz - 2018 - Pediatric Dermatology - Wiley Online Library
Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis - The Lancet Infectious Diseases
Physicians for Informed Consent - Did you know that Bexsero Meningococcal B vaccine may predispose children towards Kawasaki disease? Listed under Possible Side Effects: “Rare (these may affect up to 1 in
Post-licensure observational safety study after meningococcal B vaccine 4CMenB (Bexsero) vaccination within the routine UK immunisation program - ScienceDirect
Success of 4CMenB in preventing meningococcal disease: evidence from real-world experience | Archives of Disease in Childhood
